| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
167 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
853 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
265 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
741 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
864 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7008798 |
Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
Mar. 7, 2006 |
| 7005430 |
Fused purine derivatives |
Feb. 28, 2006 |
| 6998396 |
Diagnosis and treatment of human kidney diseases |
Feb. 14, 2006 |
| 6995151 |
Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
Feb. 7, 2006 |
| 6995152 |
Diagnosis and treatment of human kidney diseases |
Feb. 7, 2006 |
| 6989139 |
Matrix metalloproteinase inhibitors |
Jan. 24, 2006 |
| 6989162 |
Hepatoprotective agent of plant origin and a process thereof |
Jan. 24, 2006 |
| 6989275 |
Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
Jan. 24, 2006 |
| 6987102 |
Methods to mobilize progenitor/stem cells |
Jan. 17, 2006 |
| 6984635 |
Dimerizing agents, their production and use |
Jan. 10, 2006 |
| 6982269 |
Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives |
Jan. 3, 2006 |
| 6969709 |
Macrocycles useful in the treatment of Alzheimer's disease |
Nov. 29, 2005 |
| 6960574 |
Antagonists of RF-amide neuropeptides |
Nov. 1, 2005 |
| 6955804 |
Dermatological compositions and methods |
Oct. 18, 2005 |
| 6956032 |
Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
Oct. 18, 2005 |
| 6953786 |
Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof |
Oct. 11, 2005 |
| 6951848 |
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
Oct. 4, 2005 |
| 6951890 |
Preventing and/or treating cardiovascular disease and/or associated heart failure |
Oct. 4, 2005 |
| 6949257 |
Pharmaceutical compositions |
Sep. 27, 2005 |
| 6949515 |
Effectors of dipeptidyl peptidase IV for topical use |
Sep. 27, 2005 |
| 6949534 |
Cell adhesion inhibitors |
Sep. 27, 2005 |
| 6949535 |
Inhibitors of human phosphatidyl-inositol 3-kinase delta |
Sep. 27, 2005 |
| 6949536 |
Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
Sep. 27, 2005 |
| 6949537 |
PI-3 kinase inhibitor prodrugs |
Sep. 27, 2005 |
| 6949547 |
Pyrazine based inhibitors of glycogen synthase kinase 3 |
Sep. 27, 2005 |
| 6946455 |
Interstrand crosslinking agents for DNA and compounds therefor |
Sep. 20, 2005 |
| 6946456 |
Methods for treating cell proliferative disorders and viral infections |
Sep. 20, 2005 |
| 6943177 |
Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies |
Sep. 13, 2005 |
| 6936600 |
Sorbitol dehrydrogenase inhibitors |
Aug. 30, 2005 |
| 6936628 |
Oral administration of epothilones |
Aug. 30, 2005 |
| 6933260 |
Avermectin B1 derivatives having an aminosulfonyloxy substituent in the 4'-position |
Aug. 23, 2005 |
| 6933292 |
Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors |
Aug. 23, 2005 |
| 6930102 |
16-halogen-epothilone derivatives, process for their production, and their pharmaceutical use |
Aug. 16, 2005 |
| 6926892 |
Protecting plants from oomycete pathogens by treatment with compositions containing serratamolide and oocydin a from Serratia marcescens |
Aug. 9, 2005 |
| 6927214 |
Non-peptide GLP-1 agonists |
Aug. 9, 2005 |
| 6924276 |
Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
Aug. 2, 2005 |
| 6924277 |
Cyclized benzamide neurokinin antagonists for use in therapy |
Aug. 2, 2005 |
| 6924278 |
Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
Aug. 2, 2005 |
| 6919299 |
Synergistic herbicidal compositions |
Jul. 19, 2005 |
| 6919315 |
Compounds with growth hormone releasing properties |
Jul. 19, 2005 |
| 6919326 |
Carbonyl-stress improving agent and peritoneal dialysate |
Jul. 19, 2005 |
| 6916799 |
Substituted porphyrins |
Jul. 12, 2005 |
| 6916800 |
Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent |
Jul. 12, 2005 |
| 6916805 |
Quinoxalinones as serine protease inhibitors |
Jul. 12, 2005 |
| 6911428 |
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus |
Jun. 28, 2005 |
| 6911439 |
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
Jun. 28, 2005 |
| 6911440 |
Phthalazine derivatives for treating inflammatory diseases |
Jun. 28, 2005 |
| 6911478 |
Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
Jun. 28, 2005 |
| 6908911 |
Antibacterial agents |
Jun. 21, 2005 |
| 6906030 |
Carbon-substituted diketopiperazine delivery systems |
Jun. 14, 2005 |
|
|
|
